Broad specificity of human phosphoglycerate kinase for antiviral nucleoside analogs

Biochemical Pharmacology

Volumn 68, Issue 9, 2004, Pages 1749-1756

  Gallois Montbrun, Sarah ^a   Faraj, Abdesslem ^b,c   Seclaman, Edward ^a   Sommadossi, Jean Pierre ^c   Deville Bonne, Dominique ^a   Véron, Michel ^a  

^a INSTITUT PASTEUR   (France)

^b France   (France)

^c Idenix Pharmaceuticals Inc   (United States)

Author keywords

Acyclovir; Antiviral analog; l dC; l dT; NDP kinase; Phosphoglycerate kinase

Indexed keywords

ACICLOVIR; ADENOSINE; ANTIVIRUS AGENT; DEOXYCYTIDINE; DIDANOSINE; LAMIVUDINE; PHOSPHOGLYCERATE KINASE; PURINE DERIVATIVE; PYRIMIDINE NUCLEOSIDE DERIVATIVE; STAVUDINE; THYMIDINE; ZALCITABINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG ACTIVATION; DRUG MECHANISM; DRUG SPECIFICITY; ENANTIOMER; ENZYME ACTIVITY; PRIORITY JOURNAL;

ACYCLOVIR; ANTIVIRAL AGENTS; HUMANS; NUCLEOSIDE-DIPHOSPHATE KINASE; PHOSPHOGLYCERATE KINASE; PURINE NUCLEOTIDES; PYRIMIDINE NUCLEOTIDES; RECOMBINANT PROTEINS; STAVUDINE; SUBSTRATE SPECIFICITY; ZIDOVUDINE;

EID: 4644235485     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.06.012     Document Type: Article

References (31)

1. P.G.E. Krishnan, W. Lam, G.E. Dutschman, S.P. Grill, and Y.C. Cheng Novel role of 3-phosphoglycerate kinase, a glycolytic enzyme, in the activation of l-nucleoside analogs, a new class of anticancer and antiviral agents J. Biol. Chem. 278 2003 36726 36732
2. Parks Jr RE, Agarwal RP. Nucleoside diphosphokinases. The Enzymes;8:307-34.
3. J. Bourdais, R. Biondi, I. Lascu, S. Sarfati, C. Guerreiro, and J. Janin Cellular phosphorylation of anti-HIV nucleosides: role of nucleoside diphosphate kinase J. Biol. Chem. 271 1996 7887 7890
4. B. Schneider, Y.W. Xu, O. Sellam, R. Sarfati, J. Janin, and M. Veron Pre-steady state of reaction of nucleoside diphosphate kinase with anti-HIV nucleotides J. Biol. Chem. 273 1998 11491 11497
5. B. Schneider, R. Sarfati, D. Deville-Bonne, and M. Veron Role of nucleoside diphosphate kinase in the activation of anti-HIV Nucleoside analogs J. Bioenerg. Biomemb. 32 2000 317 324
6. B. Schneider, R. Biondi, R. Sarfati, F. Agou, C. Guerreiro, and D. Deville-Bonne The mechanism of phosphorylation of anti-HIV D4T by nucleoside dipshosphate kinase Mol. Pharmacol. 57 2000 948 953
7. P. Gonin, Y. Xu, L. Milon, S. Dabernat, M. Morr, and R. Kumar Catalytic mechanism of nucleoside diphosphate kinase investigated using nucleotide analogues, viscosity effects and X-ray crystallography Biochemistry 22 1999 7265 7272
8. G. Gosselin, V. Boudou, J.F. Griffon, C. Pierra, J.L. Imbach, and A.M. Aubertin New unnatural l-nucleoside enantiomers: from their stereoselective synthesis to their biological activities Nucleoside Nucleotide 16 1997 1389 1398
9. P.A. Furman, J. Wilson, J. Reardon, and G.R. Painter The effect of absolute configuration on the anti-HIV and anti-HBV activity of nucleoside analogues Antiviral Chem. Chemother. 6 1995 345 355
10. S.H. Liu, K.L. Grove, and Y.C. Cheng Unique metabolism of a novel antiviral l-nucleoside analog 2′-fluoro-5-methyl-beta-l- arabinofuranosyluracil:a substrate for both thymidine kinase and deoxycytidine kinase Antimicrob. Agents Chemother. 42 1998 833 839
11. M.L. Bryant, E.G. Bridges, L. Placidi, A. Faraj, A.G. Loi, and C. Pierra Antiviral l-nucleosides specific for hepatitis B virus infection Antimicrob. Agents Chemother. 45 2001 229 235
12. B. Hernandez-Santiago, L. Placidi, E. Cretton-Scott, A. Faraj, E.G. Bridges, and M.L. Bryant Pharmacology of β-l-thymidine and β-l-2′-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus Antimicrob. Agents Chemother. 46 2002 1728 1733
13. N. Cammack, P. Rouse, C.L. Marr, P.L. Rezid, R.E. Boehme, and J.A.V Coates Cellular metabolism of (-) enantiomeric 2′-deoxy-3′- thiacytidine Biochem. Pharmacol. 43 1993 2059 2064
14. G. Maury The enantioselectivity of enzymes involved in current antiviral therapy using nucleoside analogues: a new strategy? Antiviral Chem. Chemother. 11 2000 165 190
15. A.R. Van Rompay, M. Johansson, and A. Karlsson Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP Kinase: molecular characterization of the human enzyme Mol. Pharmacol. 56 1999 562 569
16. J.Y. Liou, G.E. Dutschman, W. Lam, Z. Jiang, and Y.C. Cheng Characterization of human UMP/CMP kinase and its phosphorylation of d- and l-form deoxycytidine analogue monophosphates Cancer Res. 62 2002 1624 1631
17. C. Pasti, S. Gallois-Montbrun, H. Munier-Lehmann, M. Veron, A.M. Gilles, and D. Deville-Bonne Reaction of human UMP-CMP kinase with natural and analog substrates Eur. J. Biochem. 270 2003 1 7
18. W.H. Miller, S.M. Daluge, E.P. Garvey, S. Hopkins, J.E. Reardon, and F.L. Boyd Phosphorylation of carbovir enantiomers by cellular enzymes determines the stereoselectivity of antiviral activity J. Biol. Chem. 267 1992 21220 21224
19. A. Kreimeyer, B. Schneider, R. Sarfati, A. Faraj, J. Sommadossi, and M. Veron NDP kinase reactivity towards 3TC nucleotides Antiviral Res. 50 2001 147 156
20. P. Krishnan, Q. Fu, W. Lam, J.Y. Liou, G. Dutschman, and Y.C. Cheng Phosphorylation of pyrimidine deoxynucleoside analog diphosphates: selective phosphorylation of l-nucleoside analog diphosphates by 3-phosphoglycerate kinase J. Biol. Chem. 277 2002 5453 5459
21. P. Krishnan, J.Y. Liou, and Y.C. Cheng Phosphorylation of pyrimidine deoxynucleoside analog diphosphates: kinetics of phosphorylation and dephosphorylation of nucleoside analog diphosphates and triphosphates by 3-phosphoglycerate kinase J. Biol. Chem. 277 2002 31593 31600
22. A.N. Szilagyi, M. Ghosh, E. Garman, and M.A. Vas 1.8 Å resolution structure of pig muscle 3-phosphoglycerate kinase with bound MgADP and 3-phophoglycerate in open conformation: new insight into the role of the nucleotide in domain closure J. Mol. Biol. 306 2001 499 511
23. A. Faraj, A. Moulay El Alaoui, G. Gosselin, J.L. Imbach, C. Morrow, and J.P. Sommadossi Effects of β-l-3′-azido-3′-deoxythymidine 5′-triphosphate on host and viral DNA polymerases Antiviral Res. 47 2000 97 102
24. J. Sambrook, E.F. Fritsch, and T. Manniatis Molecular cloning: a laboratory manual 1989 Cold Spring Harbor New York, USA
25. F. Sanger, S. Nicklen, and A.R. Coulson DNA sequencing with chain-terminating inhibitors Proc. Natl. Acad. Sci. USA 74 1977 5463 5467
26. W.K.G. Krietsch, and T. Bücher 3-Phosphoglycerate kinase from rabbit sleletal muscle and yeast Eur. J. Biochem. 17 1970 568 580
27. M.A. Sherman, B.K. Szpikowska, S.A. Dean, A.M. Mathiowetz, N.L. McQueen, and M.T. Mas Probing the role of arginines and histidines in the catalytic function and activation of yeast 3-phosphoglycerate kinase by site-directed mutagenesis J. Biol. Chem. 265 1990 10659 10685
28. B.E. Bernstein, and W.G.J. Hol Crystal structures of substrates and products bound to the phosphoglycerate kinase active site reveal the catalytic mechanism Biochemistry 37 1998 4429 4436
29. R.K. Scopes Binding of substrates and other anions to yeast phosphoglycerate kinase Eur. J. Biochem. 91 1978 119 129
30. M.B. Faletto, W.H. Miller, E.P. Garvey, M.H Clair St., S.M. Daluge, and S.S. Good Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89 Antimicrob. Agents Chemother. 41 1997 1099 1107
31. S. Gallois-Montbrun, B. Schneider, Y. Chen, V. Giocomoni-Fernandes, Mulard, and S. Morera Improving nucleotide diphosphate kinase for antiviral nucleotide analogs activation J. Biol. Chem. 277 2002 39953 39959